Long-term outcome of alcohol withdrawal seizures.
EEG
alcohol-withdrawal seizures
head trauma
mortality
risk factors
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
revised:
18
07
2023
received:
23
06
2023
accepted:
07
09
2023
pubmed:
12
10
2023
medline:
12
10
2023
entrez:
12
10
2023
Statut:
ppublish
Résumé
Alcohol withdrawal seizures (AWS) are a well-known complication of chronic alcohol abuse, but there is currently little knowledge of their long-term relapse rate and prognosis. The aims of this study were to identify risk factors for AWS recurrence and to study the overall outcome of patients after AWS. In this retrospective single-center study, we included patients who were admitted to the Emergency Department after an AWS between January 1, 2013 and August 10, 2021 and for whom an electroencephalogram (EEG) was requested. AWS relapses up until April 29, 2022 were researched. We compared history, treatment with benzodiazepines or antiseizure medications (ASMs), laboratory, EEG and computed tomography findings between patients with AWS relapse (r-AWS) and patients with no AWS relapse (nr-AWS). A total of 199 patients were enrolled (mean age 53 ± 12 years; 78.9% men). AWS relapses occurred in 11% of patients, after a median time of 470.5 days. Brain computed tomography (n = 182) showed pathological findings in 35.7%. Risk factors for relapses were history of previous AWS (p = 0.013), skull fractures (p = 0.004) at the index AWS, and possibly epileptiform EEG abnormalities (p = 0.07). Benzodiazepines or other ASMs, taken before or after the index event, did not differ between the r-AWS and the nr-AWS group. The mortality rate was 2.9%/year of follow-up, which was 13 times higher compared to the general population. Risk factors for death were history of AWS (p < 0.001) and encephalopathic EEG (p = 0.043). Delayed AWS relapses occur in 11% of patients and are associated with risk factors (previous AWS >24 h apart, skull fractures, and pathological EEG findings) that also increase the epilepsy risk, that is, predisposition for seizures, if not treated. Future prospective studies are mandatory to determine appropriate long-term diagnostic and therapeutic strategies, in order to reduce the risk of relapse and mortality associated with AWS.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Alcohol withdrawal seizures (AWS) are a well-known complication of chronic alcohol abuse, but there is currently little knowledge of their long-term relapse rate and prognosis. The aims of this study were to identify risk factors for AWS recurrence and to study the overall outcome of patients after AWS.
METHODS
METHODS
In this retrospective single-center study, we included patients who were admitted to the Emergency Department after an AWS between January 1, 2013 and August 10, 2021 and for whom an electroencephalogram (EEG) was requested. AWS relapses up until April 29, 2022 were researched. We compared history, treatment with benzodiazepines or antiseizure medications (ASMs), laboratory, EEG and computed tomography findings between patients with AWS relapse (r-AWS) and patients with no AWS relapse (nr-AWS).
RESULTS
RESULTS
A total of 199 patients were enrolled (mean age 53 ± 12 years; 78.9% men). AWS relapses occurred in 11% of patients, after a median time of 470.5 days. Brain computed tomography (n = 182) showed pathological findings in 35.7%. Risk factors for relapses were history of previous AWS (p = 0.013), skull fractures (p = 0.004) at the index AWS, and possibly epileptiform EEG abnormalities (p = 0.07). Benzodiazepines or other ASMs, taken before or after the index event, did not differ between the r-AWS and the nr-AWS group. The mortality rate was 2.9%/year of follow-up, which was 13 times higher compared to the general population. Risk factors for death were history of AWS (p < 0.001) and encephalopathic EEG (p = 0.043).
CONCLUSIONS
CONCLUSIONS
Delayed AWS relapses occur in 11% of patients and are associated with risk factors (previous AWS >24 h apart, skull fractures, and pathological EEG findings) that also increase the epilepsy risk, that is, predisposition for seizures, if not treated. Future prospective studies are mandatory to determine appropriate long-term diagnostic and therapeutic strategies, in order to reduce the risk of relapse and mortality associated with AWS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16075Subventions
Organisme : Swiss National Science Foundation
ID : 209470
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : 192749
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : 194507
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : 180365
Pays : Switzerland
Informations de copyright
© 2023 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet (London, England). 2018;392(10152):1015-1035. doi:10.1016/S0140-6736(18)31310-2
Ropper AH, Samuels MA, Joshua P, Klein SP. Adams and Victor's Principles of Neurology. McGraw-Hill Education; 2019.
Schomer DL, Lopes da Silva FH, eds. Niedermeyer's Electroencephalography. Vol 1. Oxford University Press; 2017. doi:10.1093/med/9780190228484.001.0001
Niedermeyer E, Freund G, Krumholz A. Subacute encephalopathy with seizures in alcoholics: a clinical-electroencephalographic study. Clin Electroencephalogr. 1981;12(3):113-129. doi:10.1177/155005948101200304
McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79(8):854-862. doi:10.1136/jnnp.2007.128322
Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs. 2003;17(14):1013-1030. doi:10.2165/00023210-200317140-00002
Bayard M, McIntyre J, Hill K, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician. 2004. Accessed February 27, 2021. www.aafp.org/afp;69:1443-1450.
Brathen G, Ben-Menachem E, Brodtkorb E, et al. EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol. 2005;12(8):575-581. doi:10.1111/j.1468-1331.2005.01247.x
Sand T, Bråthen G, Michler R, Brodtkorb E, Helde G, Bovim G. Clinical utility of EEG in alcohol-related seizures. Acta Neurol Scand. 2002;105(1):18-24. doi:10.1034/j.1600-0404.2002.00058.x
Rathlev NK, Ulrich AS, Delanty N, D'Onofrio G. Alcohol-related seizures. J Emerg Med. 2006;31(2):157-163. doi:10.1016/j.jemermed.2005.09.012
Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res. 2014;38(10):2664-2677. doi:10.1111/ACER.12529
D'Onofrio G, Rathlev NK, Ulrich AS, Fish SS, Freedland ES. Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med. 1999;340(12):915-919. doi:10.1056/NEJM199903253401203
Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. doi:10.1111/EPI.12550/SUPPINFO
Kim JA, Boyle EJ, Wu AC, et al. Epileptiform activity in traumatic brain injury predicts post-traumatic epilepsy. Ann Neurol. 2018;83(4):858-862. doi:10.1002/ANA.25211
Xu T, Yu X, Ou S, et al. Risk factors for posttraumatic epilepsy: a systematic review and meta-analysis. Epilepsy Behav. 2017;67:1-6. doi:10.1016/j.yebeh.2016.10.026
Geibprasert S, Gallucci M, Krings T. Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol. 2010;20(6):1492-1501. doi:10.1007/s00330-009-1668-z
Earnest MP, Feldman H, Marx JA, Harris JA, Biletch M, Sullivan LP. Intracranial lesions shown by CT scans in 259 cases of first alcohol-related seizures. Neurology. 1988;38(10):1561-1565. doi:10.1212/WNL.38.10.1561
Feussner JR, Linfors EW, Blessing CL, Starmer CF. Computed tomography brain scanning in alcohol withdrawal seizures. Value of the neurologic examination. Ann Intern Med. 1981;94(4 I):519-522. doi:10.7326/0003-4819-94-4-519
Peng J, Wang H, Rong X, et al. Cerebral hemorrhage and alcohol exposure: a review. Alcohol Alcohol. 2020;55(1):20-27. doi:10.1093/alcalc/agz087
Leung H, Man CBL, Hui ACF, Kwan P, Wong KS. Prognosticating acute symptomatic seizures using two different seizure outcomes. Epilepsia. 2010;51(8):1570-1579. doi:10.1111/j.1528-1167.2009.02409.x
Fields MC, Labovitz DL, French JA. Hospital-onset seizures. JAMA Neurol. 2013;70(3):360-364. doi:10.1001/2013.jamaneurol.337
Meyer-Wahl JG, Braun J. Epileptic seizures and cerebral atrophy in alcoholics. J Neurol. 1982;228(1):17-23. doi:10.1007/BF00313406
Kaestner E, Reyes A, Chen A, et al. Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairment. Brain. 2021;144(1):236-250. doi:10.1093/brain/awaa397
Yasuda CL, Betting LE, Cendes F. Voxel-based morphometry and epilepsy. Expert Rev Neurother. 2010;10(6):975-984. doi:10.1586/ern.10.63
Pieninkeroinen IP, Telakivi TM, Hillborn ME. Outcome in subjects with alcohol-provoked seizures. Alcohol Clin Exp Res. 1992;16(5):955-959. doi:10.1111/j.1530-0277.1992.tb01899.x
Hulme J, Sheikh H, Xie E, Gatov E, Nagamuthu C, Kurdyak P. Mortality among patients with frequent emergency department use for alcohol-related reasons in Ontario: a population-based cohort study. CMAJ. 2020;192(47):E1522-E1531. doi:10.1503/CMAJ.191730/TAB-RELATED-CONTENT
Ceylan-Isik AF, McBride SM, Ren J. Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication? Life Sci. 2010;87(5-6):133-138. doi:10.1016/J.LFS.2010.06.002
van der Zwaluw CS, Engels RCME, Buitelaar J, Verkes RJ, Franke B, Scholte RHJ. Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review. Pharmacogenomics. 2009;10(5):853-866. doi:10.2217/PGS.09.24
Urbanoski K, Cheng J, Rehm J, Kurdyak P. Frequent use of emergency departments for mental and substance use disorders. Emerg Med J. 2018;35(4):220-225. doi:10.1136/EMERMED-2015-205554
Genève. (Canton, Switzerland) - Population Statistics, Charts, Map and Location. Accessed July 10, 2022. https://www.citypopulation.de/en/switzerland/admin/25__genève/
Décès par classe d'âge, semaine et canton - 29.12.2014-26.6.2022 | Tableau | Office fédéral de la statistique. Accessed July 10, 2022. https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/naissances-deces/deces.assetdetail.22987466.html
Koh JJK, Malczewska M, Doyle MM, Moe J. Prevention of alcohol withdrawal seizure recurrence and treatment of other alcohol withdrawal symptoms in the emergency department: a rapid review. BMC Emerg Med. 2021;21(1):1-12. doi:10.1186/S12873-021-00524-1/TABLES/2
Martinotti G, Lupi M, Sarchione F, et al. The potential of Pregabalin in neurology, psychiatry and addiction: a qualitative overview. Curr Pharm Des. 2013;19(35):6367-6374. doi:10.2174/13816128113199990425
Bahji A, Bach P, Danilewitz M, et al. Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis. Addiction. 2022;117(10):2591-2601. doi:10.1111/add.15853
Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010;3:27-30. doi:10.1002/14651858.CD005064.pub3
Stephen Rich J, Martin PR. Co-occurring psychiatric disorders and alcoholism. Handb Clin Neurol. 2014;125:573-588. doi:10.1016/B978-0-444-62619-6.00033-1